Blood–brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteinsLeah Hernandez, Louise Pilote, Colleen M. Norris et al.|Scientific Reports|2022Cited by 64
Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortalityAgnė Laučytė-Cibulskienė, Karolina Kublickiene, Liam J. Ward et al.|Biology of Sex Differences|2021Cited by 30
Identification of cystatin C as a new marker of glomerular filtration rate, and of shrunken pore syndrome – a new kidney disorder defining selective glomerular hypofiltration syndromes – calls for expansion of the international KDIGO guidelinesAnna Åkesson, Anders Grubb, Carl M. Öberg et al.|Scandinavian Journal of Clinical and Laboratory Investigation|2025Cited by 5